Gene · 5737
Papers1,138
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1 to 20 of 1,138
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Establishment of a Predictive Model for Mortality in Sepsis Patients Using WGCNA and Machine Learning Algorithms. | J Inflamm Res | 2026 | 42605381 | PubTator, text mining | PubMed |
| Topical latanoprost acid for female androgenetic alopecia: a pilot proof-of-concept trial with mechanistic evidence of prostaglandin F2α receptor activation. | Pharmacol Rep | 2026 | 42430069 | PubTator, text mining | PubMed |
| An environmentally relevant phthalate mixture impairs ovulatory prostaglandin and progesterone receptor pathways in human granulosa cells in vitro. | Environ Int | 2026 | 41807910 | PubTator, text mining | PubMed |
| Regulatory roles of bioactive lipids in vascular homeostasis and remodeling. | Med Rev (2021) | 2026 | 41783891 | PubTator, text mining | PubMed |
| Use of genetics in the prediction of success in male pattern hair loss therapy and mechanistic studies. | Front Pharmacol | 2026 | 41769701 | PubTator, text mining | PubMed |
| Structural and Biophysical Analyses of Human Prostamide/Prostaglandin F Synthase with Two Active Form-Mimicking Mutations. | Biomolecules | 2026 | 41750332 | PubTator, text mining | PubMed |
| Bioengineering of extracellular vesicles with scaffold proteins for drug delivery. | J Nanobiotechnology | 2026 | 41680844 | PubTator, text mining | PubMed |
| Unveiling novel potential drug targets for lung cancer through Mendelian randomization analysis. | Sci Rep | 2025 | 41436647 | PubTator, text mining | PubMed |
| Novel N‑Arylquinoline-4-carboxamide Derivatives as Prostaglandin F Receptor Antagonists. | ACS Med Chem Lett | 2025 | 41257019 | PubTator, text mining | PubMed |
| Glaucoma diagnosis and treatment in the era of precision medicine. | Pharmacogenomics | 2025 | 41147667 | PubTator, text mining | PubMed |
| The Effect of Preoperative Use of High- vs. Low-PAP-Inducing-Potential FP Agonists on the Surgical Outcomes of Trabeculectomy and AGV Implantation. | J Clin Med | 2025 | 41096020 | PubTator, text mining | PubMed |
| Lysosome-related molecular subtypes reveal prognostic signatures and immunotherapeutic implications in ovarian cancer. | Sci Rep | 2025 | 40998924 | PubTator, text mining | PubMed |
| Arachidonic acid metabolism in metabolic dysfunction-associated steatotic liver disease and liver fibrosis. | Hepatol Commun | 2025 | 40879475 | PubTator, text mining | PubMed |
| Genome-wide interaction study of physical activity and genetic susceptibility on colorectal cancer using UK biobank data. | Sci Rep | 2025 | 40826151 | PubTator, text mining | PubMed |
| The impact of sarcopenia on prognosis and fruquintinib efficacy in advanced colorectal cancer: a retrospective and mendelian randomization study. | Front Immunol | 2025 | 40740773 | PubTator, text mining | PubMed |
| A systems-based approach to uterine fibroids identifies differential splicing associated with abnormal uterine bleeding. | Commun Med (Lond) | 2025 | 40739398 | PubTator, text mining | PubMed |
| Prostaglandin F2α exacerbated dry eye by promoting lacrimal gland fibrosis progression through the activation of the RhoA/ROCKs signaling pathway. | Ocul Surf | 2025 | 40685078 | PubTator, text mining | PubMed |
| Optimization of the prostaglandin F2α receptor for structural biology. | PLoS One | 2025 | 40680049 | PubTator, text mining | PubMed |
| Increased sensitivity of primary aniridia limbal stromal cells to travoprost, leading to elevated migration and MMP-9 protein levels, in vitro. | PLoS One | 2025 | 40570009 | PubTator, text mining | PubMed |
| The inhibition of prostaglandin production during ovulation by exposure to a phthalate mixture is circumvented by cAMP analogue supplementation in a human granulosa cell model. | Reprod Toxicol | 2025 | 40456493 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5737/papers